CGAS and neurodegenerative disease: A more refined mechanistic understanding of how DNA ligands, including mitochondrial DNA, trigger cGAS in autoinflammatory, autoimmune, and degenerative diseases may further inform therapeutic modulation strategies upstream of cGAS.